Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase Ib Phase Ib stage: To determine the recommended dose (RD) of the combination of trabectedin and oxaliplatin in patients with advanced ovarian cancer. Phase II Phase II stage: To determine the antitumor activity of the combination of trabectedin and oxaliplatin, administered at the RD established in the phase Ib stage, in patients with advanced ovarian cancer.
Critère d'inclusion
- Pretreated Advanced Ovarian Cancer